tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies Stock Forecast & Price Target

361 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
9Ratings
9 Buy
0 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Taysha
Gene Therapies
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TSHA Stock Price Prediction

Average Price Target

$22.25
▲(969.71% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Taysha Gene Therapies in the last 3 months. The average price target is $22.25 with a high forecast of $32.00 and a low forecast of $5.00. The average price target represents a 969.71% change from the last price of $2.08.
Highest Price Target$32.00Average Price Target$22.25Lowest Price Target$5.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Guggenheim
Buy
Reiterated
Taysha Gene Therapies (TSHA) PT Lowered to $24 at GuggenheimGuggenheim analyst Debjit Chattopadhyay lowered the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $24.00 (from $28.00) while maintaining a Buy rating.
Oppenheimer
$37.00
Buy
1678.85%
Upside
Reiterated
Taysha Gene Therapies (TSHA) PT Lowered to $37 at OppenheimerOppenheimer analyst Kevin DeGeeter lowered the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $37.00 (from $45.00) while maintaining a Outperform rating.
Truist Financial
$35.00
Buy
1582.69%
Upside
Reiterated
Taysha Gene Therapies (TSHA) PT Lowered to $35 at Truist SecuritiesTruist Securities analyst Joon Lee lowered the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $35.00 (from $60.00) while maintaining a Buy rating.
Morgan Stanley
$39.00
Buy
1775.00%
Upside
Initiated
Taysha Gene Therapies assumed with an Overweight at Morgan StanleyTaysha Gene Therapies assumed with an Overweight at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

TSHA Stock Forecast FAQ

What is TSHA’s average 12-month price target, according to analysts?
Based on analyst ratings, Taysha Gene Therapies’s 12-month average price target is $22.25.
    What is TSHA’s upside potential, based on the analysts’ average price target?
    Taysha Gene Therapies has 969.71% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TSHA a Buy, Sell or Hold?
          Taysha Gene Therapies has a conensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Taysha Gene Therapies’s price target?
            The average price target for Taysha Gene Therapies is $22.25. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $32.00 ,the lowest forecast is $5.00. The average price target represents 969.71% Increase from the current price of $2.08.
              What do analysts say about Taysha Gene Therapies?
              Taysha Gene Therapies’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis